314 related articles for article (PubMed ID: 18037944)
1. Reduced intensity conditioning and allogeneic stem cell transplantation in childhood malignant and nonmalignant diseases.
Satwani P; Cooper N; Rao K; Veys P; Amrolia P
Bone Marrow Transplant; 2008 Jan; 41(2):173-82. PubMed ID: 18037944
[TBL] [Abstract][Full Text] [Related]
2. Incidence of Viral and fungal infections following busulfan-based reduced-intensity versus myeloablative conditioning in pediatric allogeneic stem cell transplantation recipients.
Satwani P; Baldinger L; Freedman J; Jacobson JS; Guerra J; van de Ven C; Morris E; Garvin J; George D; Bradley MB; Bhatia M; Tallamy B; Schwartz J; Jin Z; Cairo MS
Biol Blood Marrow Transplant; 2009 Dec; 15(12):1587-95. PubMed ID: 19896083
[TBL] [Abstract][Full Text] [Related]
3. Improved outcome of treatment-resistant high-risk Langerhans cell histiocytosis after allogeneic stem cell transplantation with reduced-intensity conditioning.
Steiner M; Matthes-Martin S; Attarbaschi A; Minkov M; Grois N; Unger E; Holter W; Vormoor J; Wawer A; Ouachee M; Woessmann W; Gadner H
Bone Marrow Transplant; 2005 Aug; 36(3):215-25. PubMed ID: 15937510
[TBL] [Abstract][Full Text] [Related]
4. [Immune reconstitution after allogeneic stem cell transplantation using nonmyeloablative or reduced-intensity conditioning regimen].
Nakai K
Nihon Rinsho; 2003 Sep; 61(9):1542-8. PubMed ID: 14515721
[TBL] [Abstract][Full Text] [Related]
5. Reduced-intensity allogeneic stem cell transplantation in adults and children with malignant and nonmalignant diseases: end of the beginning and future challenges.
Satwani P; Harrison L; Morris E; Del Toro G; Cairo MS
Biol Blood Marrow Transplant; 2005 Jun; 11(6):403-22. PubMed ID: 15931629
[TBL] [Abstract][Full Text] [Related]
6. Decreased RBCTs after reduced intensity conditioning allogeneic stem cell transplantation: predictive value of prior Hb level.
Ivanov V; Faucher C; Mohty M; Bilger K; Ladaique P; Sainty D; Arnoulet C; Chabannon C; Vey N; Camerlo J; Bouabdallah R; Maraninchi D; Bardou VJ; Blaise D
Transfusion; 2004 Apr; 44(4):501-8. PubMed ID: 15043564
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic stem cell transplantation after reduced-intensity conditioning in lymphoid malignancies.
Sureda A; Schmitz N
Ann Hematol; 2003 Jan; 82(1):1-13. PubMed ID: 12574957
[TBL] [Abstract][Full Text] [Related]
8. Advantages and limitations of (non-)myeloablative allogeneic stem cell transplantation.
Huugen D; Schouten HC; Bos GM
Neth J Med; 2002 May; 60(4):162-9. PubMed ID: 12164394
[TBL] [Abstract][Full Text] [Related]
9. Reduced-intensity conditioning regimens in malignant haematological diseases.
Buffart TE; Janssen JJ; Huijgens PC
Neth J Med; 2005 Feb; 63(2):43-51. PubMed ID: 15766008
[TBL] [Abstract][Full Text] [Related]
10. Immune reconstitution after allogeneic stem cell transplantation with reduced-intensity conditioning regimens.
Jiménez M; Ercilla G; Martínez C
Leukemia; 2007 Aug; 21(8):1628-37. PubMed ID: 17525730
[TBL] [Abstract][Full Text] [Related]
11. Reduced intensity conditioning in unrelated donor transplantation for refractory cytopenia in childhood.
Strahm B; Locatelli F; Bader P; Ehlert K; Kremens B; Zintl F; Führer M; Stachel D; Sykora KW; Sedlacek P; Baumann I; Niemeyer CM
Bone Marrow Transplant; 2007 Aug; 40(4):329-33. PubMed ID: 17589538
[TBL] [Abstract][Full Text] [Related]
12. Reduced-intensity conditioning in children: a reappraisal in 2008.
Yaniv I; Stein J;
Bone Marrow Transplant; 2008 Jun; 41 Suppl 2():S18-22. PubMed ID: 18545237
[TBL] [Abstract][Full Text] [Related]
13. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
[TBL] [Abstract][Full Text] [Related]
14. Reduced intensity and non-myeloablative allogeneic stem cell transplantation in children and adolescents with malignant and non-malignant diseases.
Satwani P; Morris E; Bradley MB; Bhatia M; van de Ven C; Cairo MS
Pediatr Blood Cancer; 2008 Jan; 50(1):1-8. PubMed ID: 17668859
[TBL] [Abstract][Full Text] [Related]
15. Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma.
de Lavallade H; El-Cheikh J; Faucher C; Fürst S; Stoppa AM; Coso D; Bouabdallah R; Chabannon C; Gastaut JA; Blaise D; Mohty M
Bone Marrow Transplant; 2008 Jun; 41(11):953-60. PubMed ID: 18297115
[TBL] [Abstract][Full Text] [Related]
16. Stem cell transplantation for children with Glanzmann thrombasthenia.
Connor P; Khair K; Liesner R; Amrolia P; Veys P; Ancliff P; Mathias M
Br J Haematol; 2008 Mar; 140(5):568-71. PubMed ID: 18205861
[TBL] [Abstract][Full Text] [Related]
17. Indications and donor selections for allogeneic stem cell transplantation in children with hematologic malignancies.
Handgretinger R; Kurtzberg J; Egeler RM
Pediatr Clin North Am; 2008 Feb; 55(1):71-96, x. PubMed ID: 18242316
[TBL] [Abstract][Full Text] [Related]
18. Assessment of disseminated adenovirus infections using quantitative plasma PCR in adult allogeneic stem cell transplant recipients receiving reduced intensity or myeloablative conditioning.
Kalpoe JS; van der Heiden PL; Barge RM; Houtzager S; Lankester AC; van Tol MJ; Kroes AC
Eur J Haematol; 2007 Apr; 78(4):314-21. PubMed ID: 17331130
[TBL] [Abstract][Full Text] [Related]
19. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
20. Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure.
Subirà M; Sureda A; Ancín I; Martino R; Altés A; Brunet S; Sierra J
Bone Marrow Transplant; 2003 Nov; 32(9):869-72. PubMed ID: 14561986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
